A specific genetic variation in the MTHFR C677T gene is associated with subclinical hypothyroidism in early pregnancy, according to a 2026 case-control study of 400 pregnant women. Gram Research analysis shows that women with the TT genetic variant had significantly higher thyroid-stimulating hormone levels, suggesting reduced thyroid function. Being overweight before pregnancy and having a history of anemia also increased risk, indicating that thyroid problems in pregnancy result from multiple factors rather than genetics alone.
Researchers studied 400 pregnant women to understand why some develop subclinical hypothyroidism—a condition where the thyroid doesn’t work quite right but doesn’t cause obvious symptoms. They discovered that women with a specific genetic variation in the MTHFR gene were more likely to have this thyroid problem early in pregnancy. The study also found that being overweight before pregnancy and having a history of anemia increased the risk. While this research helps explain why some pregnant women develop thyroid issues, doctors say more studies are needed before making major changes to how they screen or treat pregnant women.
Key Statistics
A 2026 case-control study of 400 pregnant women found that women with the MTHFR C677T TT genetic variant had significantly higher TSH levels compared to those with CC or CT variants, suggesting weaker thyroid function.
According to research reviewed by Gram, abnormal pre-pregnancy body mass index and anemia history were significantly more common in pregnant women with subclinical hypothyroidism than in those with normal thyroid function.
The MTHFR A1298C genetic variant showed no significant association with subclinical hypothyroidism in the 2026 study, indicating that different MTHFR variations have different effects on thyroid health.
The Quick Take
- What they studied: Whether a specific genetic variation (a tiny difference in your DNA) makes it more likely for pregnant women to develop a sluggish thyroid that doesn’t show obvious symptoms
- Who participated: 400 pregnant women in China: 100 with subclinical hypothyroidism and 300 with normal thyroid function, studied between 2021 and 2024
- Key finding: Women with the TT genetic variant of the MTHFR C677T gene had higher thyroid-stimulating hormone (TSH) levels, suggesting a weaker thyroid. This genetic variant was significantly linked to subclinical hypothyroidism
- What it means for you: If you’re planning pregnancy or are pregnant, knowing your genetic makeup might help doctors predict thyroid problems earlier. However, this research is still preliminary—talk to your doctor before making any decisions based on genetic testing
The Research Details
This was a case-control study, which means researchers compared two groups of pregnant women: those who already had subclinical hypothyroidism and those with normal thyroid function. They looked backward at medical records from a hospital in China between 2021 and 2024. The researchers tested the women’s DNA to find specific genetic variations in the MTHFR gene and measured their thyroid hormone levels. They used a technique called PCR-RFLP, which is like a genetic fingerprinting method that identifies tiny variations in DNA sequences. Then they used statistical analysis to see if the genetic variations were more common in women with thyroid problems.
Case-control studies are useful for finding connections between genes and diseases because they let researchers compare people who already have a condition with those who don’t. This approach is faster and cheaper than following people over time. Understanding which genetic variations increase thyroid disease risk could help doctors identify pregnant women who need extra monitoring or early treatment, potentially preventing complications for both mother and baby.
This study has moderate reliability. Strengths include a reasonable sample size (400 women) and clear measurement of both genetic and thyroid markers. Limitations include being conducted at a single hospital in one country, which may not represent all populations. The study is retrospective, meaning it looks at past records rather than following women forward in time. The researchers didn’t measure all possible confounding factors that might affect thyroid health, such as iodine intake or stress levels.
What the Results Show
Women with the TT genetic variant of the MTHFR C677T gene had significantly higher TSH levels compared to women with CC or CT variants. TSH is a hormone that tells your thyroid to work harder—higher levels suggest the thyroid isn’t working as efficiently. The association was strong across multiple statistical models, meaning the connection held up under different ways of analyzing the data. Importantly, the other genetic variant studied (A1298C) showed no significant association with subclinical hypothyroidism, suggesting that not all MTHFR variations affect thyroid function equally.
The study identified two additional risk factors for subclinical hypothyroidism in pregnancy: abnormal pre-pregnancy body mass index (BMI) and a history of anemia. Women in the SCH group were significantly more likely to have been overweight or underweight before pregnancy and to have had anemia previously. These findings suggest that thyroid problems in pregnancy may result from multiple factors working together—genetics, weight status, and iron metabolism—rather than a single cause.
This research adds to growing evidence that MTHFR gene variations affect thyroid function, particularly during pregnancy when thyroid demands increase. Previous studies have suggested MTHFR polymorphisms influence folate metabolism, which is critical for thyroid hormone production. This study is among the first to specifically examine this connection in early pregnancy, a vulnerable period when thyroid problems can affect fetal development. The findings align with known associations between anemia and thyroid dysfunction, as both conditions involve similar metabolic pathways.
This study has several important limitations. It only included women from one hospital in China, so results may not apply to other populations with different genetic backgrounds. The study looked backward at medical records rather than following women forward, which can introduce bias. Researchers didn’t measure important factors like iodine intake, selenium levels, or stress—all of which affect thyroid function. The sample size, while reasonable, was relatively small for genetic studies. Finally, the study couldn’t prove that the genetic variation actually causes thyroid problems; it only shows an association.
The Bottom Line
According to Gram Research analysis, pregnant women or those planning pregnancy should discuss thyroid screening with their doctor, especially if they have a family history of thyroid disease, are overweight, or have had anemia. Genetic testing for MTHFR variants is not yet recommended as routine screening, but may be worth discussing with a genetic counselor if you have multiple risk factors. Ensuring adequate folate, iron, and iodine intake before and during pregnancy supports thyroid health. These recommendations have moderate confidence because the research is still preliminary.
This research is most relevant for pregnant women or those planning pregnancy, particularly those with risk factors like obesity, anemia, or family history of thyroid disease. Women of reproductive age considering genetic testing may find this information useful. Healthcare providers should be aware of these associations when screening pregnant patients. This research is less immediately relevant for non-pregnant individuals, though it may inform future personalized medicine approaches.
Thyroid problems develop gradually, so benefits from addressing these risk factors would likely appear over weeks to months. If you’re planning pregnancy, optimizing weight and treating anemia before conception may reduce risk. If you’re already pregnant, thyroid monitoring should begin early, ideally in the first trimester, when thyroid hormone is most critical for fetal brain development.
Frequently Asked Questions
Can a gene test predict if I’ll have thyroid problems during pregnancy?
A genetic test for the MTHFR C677T variant may help identify increased risk, but cannot predict thyroid problems with certainty. Multiple factors—including weight, anemia history, and iodine intake—also influence thyroid function. Discuss genetic testing with your doctor or genetic counselor.
What should I do if I’m overweight and planning to get pregnant?
Achieving a healthy weight before pregnancy reduces thyroid disease risk and improves overall pregnancy outcomes. Work with your healthcare provider on a safe weight management plan. Ensure adequate folate and iron intake, as these nutrients support thyroid function.
Does having anemia increase my risk of thyroid problems in pregnancy?
Research shows a significant association between anemia history and subclinical hypothyroidism in pregnancy. Both conditions involve similar metabolic pathways. If you have anemia, treating it before pregnancy and maintaining adequate iron levels may reduce thyroid risk.
How early in pregnancy should thyroid screening happen?
Thyroid screening should ideally occur before pregnancy or in the first trimester, when thyroid hormone is most critical for fetal brain development. If you have risk factors like obesity or anemia history, discuss early screening with your healthcare provider.
Is this genetic finding going to change how doctors treat pregnant women?
Not yet. While this research identifies an important association, doctors need larger, prospective studies before changing standard care. Current thyroid screening practices remain based on TSH levels and symptoms, not genetic testing.
Want to Apply This Research?
- Track pre-pregnancy BMI and monitor weight changes during pregnancy. Log any history of anemia, iron supplementation, and thyroid screening results. Record TSH levels at each prenatal visit to identify trends.
- Users can set reminders to take prenatal vitamins with adequate folate and iron, maintain a healthy weight through appropriate nutrition and exercise, and schedule thyroid screening appointments as recommended by their healthcare provider.
- Create a timeline tracking thyroid function tests from pre-pregnancy through each trimester. Compare TSH levels across visits to identify any upward trends. Link this data with weight tracking and iron supplementation logs to identify patterns.
This article summarizes research findings and is not medical advice. Thyroid disorders in pregnancy require professional medical evaluation and treatment. If you are pregnant or planning pregnancy, consult your healthcare provider about appropriate thyroid screening, genetic testing, and management. Do not make changes to thyroid medication or supplementation based on this article without medical guidance. Genetic testing should be discussed with a qualified genetic counselor or physician who can interpret results in the context of your individual health history.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.